Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial

著者: Atul Deodhar, Filip Van den Bosch, Denis Poddubnyy, Walter P. Maksymowych, Désirée van der Heijde, Tae‐Hwan Kim, Mitsumasa Kishimoto, Ricardo Blanco, Yuanyuan Duan, Yihan Li, Aileen L. Pangan, Peter Wung, In‐Ho Song - The Lancet 2022 被引用: 135